0.25 CME Credit
A Wake-Up Call: Sleep Apnea's Impact on Cognitive Health - Frankly Speaking Ep 347Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato
In this episode, we’re diving into recent research that uncovers a compelling link between obstructive sleep apnea and cognitive decline in older adults. Join expert faculty as they dissect the findings and provide invaluable insights to comprehensively address this connection in your practice.
Episode references and resource links:
- Marchi, NA, Solelhac, G, Berger,M, Haba-Rubio, J, Gosselin, N, Vollenweider, P, Marques-Vidal, P, Popp, J, vonGunten, A, Preisig, M, Draganski, B, Heinzer, R. Obstructive sleep apnoea and 5-year cognitive decline in the elderly; European Respiratory Journal Apr 2023, 61 (4) 2201621; DOI: 10.1183/13993003.01621-2022
- Dunietz GL, Chervin RD, Burke JF, Conceicao AS, Braley TJ. Obstructive sleep apnea treatment and dementia risk in older adults. Sleep. 2021;44(9):zsab076. doi:10.1093/sleep/zsab076
DynaMed – OSA: https://www-dynamed-com.umassmed.idm.oclc.org/condition/obstructive-sleep-apnea-osa-in-adults
Already listened on another platform?
- Discuss recent evidence that links obstructive sleep apnea (OSA) to cognitive decline risk in older people
- Describe ways to incorporate this new evidence to identify OSA and reduce the risk of cognitive decline
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Susan Feeney, DNP, FNP-BC, NP-C
Assistant Professor, Family Nurse Practitioner Program Coordinator, Graduate School of Nursing, University of Massachusetts Chan Medical School, Worcester, MALearn More
Frank J. Domino, MD: Has disclosed no relevant financial relationships.
Susan Feeney, DNP, FNP-BC, NP-C: Has disclosed no relevant financial relationships.
Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
AMA PRA Category 1 Credits
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Obtaining Credit
For APRNs and PAs, AANPCB and NCCPA accept AMA PRA Category 1 Credit™ as the number of hours of participation (AANPCB) or as Category 1 CME credits (NCCPA).
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions? If you have questions about this activity, please email firstname.lastname@example.org or call (877) 477-4633.